NEKTAR THERAPEUTICS
NKTR · Pharmaceutical Preparations
Latest available SEC filing: 4 ·
Latest disclosures
-
Whitfield Roy A: Form 4
Insider disclosure · Filed · Report period 23 Sep 2026
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Latest financial period: Q2 2026
Financial facts · Filed
Institutional holders by security
Choose a share class to see reported 13F positions and quarterly changes. Different securities have separate holder histories.
Company details and SEC sources
CIK 0000906709 · SEC filing index. Filing dates describe disclosures, not live market data.
- Listed symbols
- NKTR on Nasdaq
- SEC industry group
- Pharmaceutical Preparations (Office of Life Sciences)
- Business address
- 455 Mission Bay Boulevard South, San Francisco, CA, 94158
- Incorporated in
- DE
- Fiscal year end
- 31 December
- Former names on EDGAR
- INHALE THERAPEUTIC SYSTEMS INC (to 10 Jan 2003), INHALE THERAPEUTIC SYSTEMS (to 14 May 1998)
At a glance
Names, identifiers, and filing context for this profile.
2 identity fields